Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved publishing date : 2021 - 12 - 15 save search
Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management
Published: 2021-12-15 (Crawled : 23:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
acuvue fda fda approval approval
Winnebago Industries Board of Directors Approves Quarterly Cash Dividend
Published: 2021-12-15 (Crawled : 23:00) - globenewswire.com
WGO | $64.58 -0.62% 0.0% 410K
|
Consumer Durables
|
| O: 0.36%
H: 0.0%
C: 0.0%
Home BancShares, Inc. Announces Shareholder Approval in Connection with Happy Bancshares, Inc. Acquisition
Published: 2021-12-15 (Crawled : 23:00) - globenewswire.com
HOMB | $24.8 0.45% 0.0% 890K
|
Finance
|
| O: 0.86%
H: 0.98%
C: -1.22%
acquisition approval
Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
Published: 2021-12-15 (Crawled : 21:00) - eagleus.com
EGRX | $4.58 -3.98% -4.15% 95K
|
Health Technology
|
| O: 0.08%
H: 0.59%
C: -0.69%
fda als fda approval approval
Eli Lilly’s Two-Year Ambition Includes Alzheimer’s Approvals
Published: 2021-12-15 (Crawled : 19:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 4.7%
H: 0.0%
C: 0.0%
alzheimer als approval alzheimer’s alzheimer's
I-Mab Receives IND Approval for Phase 1 Clinical Trial of Bispecific Antibody TJ-CD4B in Solid Tumors in China
Published: 2021-12-15 (Crawled : 15:30) - biospace.com/
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -11.41%
H: 8.08%
C: 7.32%
solid tumors trial approval phase 1 china antibody phase 2
Aspaveli® (pegcetacoplan) approved in EU as orphan drug for treatment of PNH
Published: 2021-12-15 (Crawled : 13:00) - biospace.com/
APLS G | $49.84 2.3% 2.25% 1.2M
|
Health Technology
|
| O: 4.61%
H: 4.76%
C: 3.38%
aspaveli treatment drug orphan drug
Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve
Published: 2021-12-15 (Crawled : 13:00) - biospace.com/
ARAY | $2.2 -0.9% -0.91% 290K
|
Health Technology
|
| O: -2.71%
H: 4.5%
C: 4.28%
cyberknife chronic pain approval
Apellis and Sobi Announce EU Approval of Aspaveli® (pegcetacoplan) for Treatment of PNH
Published: 2021-12-15 (Crawled : 12:30) - globenewswire.com
APLS G | $49.84 2.3% 2.25% 1.2M
|
Health Technology
|
| O: 4.61%
H: 4.76%
C: 3.38%
aspaveli treatment approval
ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features
Published: 2021-12-15 (Crawled : 12:30) - biospace.com/
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: -3.07%
H: 3.96%
C: 3.96%
clearance radiation therapy therapy
PREIT Makes Meaningful Progress on Key Balance Sheet Improvement Initiatives, Securing Extension of Woodland Mall Mortgage and Unappealable Approval on Multi-Family Development at Moorestown Mall
Published: 2021-12-15 (Crawled : 12:00) - preit.com
PEI 4 | $2.39 0.0%
|
Finance
|
| O: -1.45%
H: 3.92%
C: 1.96%
approval tga
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.